These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24191217)

  • 21. [HPV vaccination and testing can improve cervix cancer screening].
    Bistoletti P; Andersson S; Johansson BC
    Lakartidningen; 2008 Jan 9-15; 105(1-2):56-7. PubMed ID: 18293750
    [No Abstract]   [Full Text] [Related]  

  • 22. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical human papillomavirus screening among older women.
    Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
    Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-sampling HPV testing versus mainstream cervical screening and HPV testing.
    Farnsworth A
    Med J Aust; 2016 Mar; 204(5):171. PubMed ID: 26985836
    [No Abstract]   [Full Text] [Related]  

  • 25. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV-vaccine and screening programs: the new era of global prevention.
    Mariani L
    J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
    [No Abstract]   [Full Text] [Related]  

  • 28. Human papillomavirus testing for primary screening of cervical cancer precursors.
    Ratnam S; Franco EL; Ferenczy A
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV testing. Visible expectations and hidden realities.
    Federschneider JM; Crum CP
    Am J Clin Pathol; 2003 Oct; 120(4):483-4. PubMed ID: 14560559
    [No Abstract]   [Full Text] [Related]  

  • 30. [EUROGIN 2010: roadmap on cervical cancer prevention].
    Monsonego J
    Gynecol Obstet Fertil; 2011; 39(7-8):462-7. PubMed ID: 21764621
    [No Abstract]   [Full Text] [Related]  

  • 31. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus infection (HPV) & screening strategies for cervical cancer.
    Sehgal A; Singh V
    Indian J Med Res; 2009 Sep; 130(3):234-40. PubMed ID: 19901432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HPV test makes cytological examination more accurate. Cervical cancer can be discovered more efficiently].
    Andersson S; Hjerpe A; Johansson BC; Hagmar B
    Lakartidningen; 2007 Sep 26-Oct 2; 104(39):2797-9. PubMed ID: 17958005
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 36. Human papillomavirus testing, vaccination, and gynecologic screening: fight or flight?
    Covell JL; Stoler MH
    Am J Clin Pathol; 2007 Nov; 128(5):726-8. PubMed ID: 17951192
    [No Abstract]   [Full Text] [Related]  

  • 37. [Integrating HPV testing for primary screening?].
    Riethmuller D; Ramanah R; Pretet JL; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective.
    Farnsworth A
    Acta Cytol; 2011; 55(4):307-12. PubMed ID: 21791898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology.
    Boon ME; Rijkaart DC; Ouwerkerk-Noordam E; Korporaal H
    Diagn Cytopathol; 2006 Sep; 34(9):644-8. PubMed ID: 16900471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.